Literature DB >> 21945859

Epigenetic mechanisms in developmental programming of adult disease.

Man Chen1, Lubo Zhang.   

Abstract

Adverse insults during intrauterine life can result in permanent changes in the physiology and metabolism of the offspring, which in turn leads to an increased risk of disease in adulthood. This is an adaptational response by the fetus to changes in the environmental signals that it receives during early life to ensure its survival and prepare itself for postnatal life. Increasing evidence suggests that the epigenetic regulation of gene expression patterns has a crucial role in the developmental programming of adult disease. This review summarizes recent studies of epigenetic mechanisms and focuses particularly on studies that explore identifiable epigenetic biomarkers in the promoters of specific disease-associated genes. Such biomarkers would enable early recognition of children who might be at risk of developing adult disease with fetal origins.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945859      PMCID: PMC3226870          DOI: 10.1016/j.drudis.2011.09.008

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  157 in total

1.  Long-lasting adverse effects of prenatal hypoxia on developing autonomic nervous system and cardiovascular parameters in rats.

Authors:  Julie Peyronnet; Yvette Dalmaz; Marcus Ehrström; Julie Mamet; Jean-Christophe Roux; Jean-Marc Pequignot; H Peter Thorén; Hugo Lagercrantz
Journal:  Pflugers Arch       Date:  2002-01-24       Impact factor: 3.657

Review 2.  The role of RNA interference in heterochromatic silencing.

Authors:  Zachary Lippman; Rob Martienssen
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Genomic imprinting and reproduction.

Authors:  A K E Swales; N Spears
Journal:  Reproduction       Date:  2005-10       Impact factor: 3.906

Review 4.  Tilling the chromatin landscape: emerging methods for the discovery and profiling of protein-DNA interactions.

Authors:  Benjamin A T Rodriguez; Tim H-M Huang
Journal:  Biochem Cell Biol       Date:  2005-08       Impact factor: 3.626

Review 5.  Fetal nutrition and cardiovascular disease in adult life.

Authors:  D J Barker; P D Gluckman; K M Godfrey; J E Harding; J A Owens; J S Robinson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

Review 6.  DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.

Authors:  Johanna K Samuelsson; Sergio Alonso; Fumiichiro Yamamoto; Manuel Perucho
Journal:  Mutat Res       Date:  2010-09-17       Impact factor: 2.433

7.  The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction.

Authors:  Esther M E van Straten; Vincent W Bloks; Nicolette C A Huijkman; Julius F W Baller; Hester van Meer; Dieter Lütjohann; Folkert Kuipers; Torsten Plösch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

Review 8.  Mammalian epigenomics: reprogramming the genome for development and therapy.

Authors:  W Reik; F Santos; W Dean
Journal:  Theriogenology       Date:  2003-01-01       Impact factor: 2.740

9.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

Authors:  Jun H Park; Doris A Stoffers; Robert D Nicholls; Rebecca A Simmons
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 10.  The many faces of histone lysine methylation.

Authors:  Monika Lachner; Thomas Jenuwein
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

View more
  29 in total

Review 1.  Epigenetic inheritance of disease and disease risk.

Authors:  Johannes Bohacek; Isabelle M Mansuy
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

2.  The placenta is the center of the chronic disease universe.

Authors:  Kent L Thornburg; Nicole Marshall
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

3.  Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring.

Authors:  Eliel Kedar Sade; Tamar Wainstock; Erez Tsumi; Eyal Sheiner
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

4.  Physiology's impact: discovering life.

Authors:  Gary C Sieck; Gabriel G Haddad; Pamela Lucchesi
Journal:  Physiology (Bethesda)       Date:  2013-03

Review 5.  Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.

Authors:  Yong Li; Pablo Gonzalez; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2012-05-22       Impact factor: 11.685

Review 6.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

7.  Embryonic Atrazine Exposure Elicits Alterations in Genes Associated with Neuroendocrine Function in Adult Male Zebrafish.

Authors:  Sara E Wirbisky; Maria S Sepúlveda; Gregory J Weber; Amber S Jannasch; Katharine A Horzmann; Jennifer L Freeman
Journal:  Toxicol Sci       Date:  2016-07-13       Impact factor: 4.849

8.  Prenatal Hypoxia Induces Premature Aging Accompanied by Impaired Function of the Glutamatergic System in Rat Hippocampus.

Authors:  Oleg Vetrovoy; Viktor Stratilov; Peter Nimiritsky; Pavel Makarevich; Ekaterina Tyulkova
Journal:  Neurochem Res       Date:  2021-01-02       Impact factor: 3.996

Review 9.  Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2014-11-11       Impact factor: 11.685

10.  Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes.

Authors:  Ning Xu; Angela K Chua; Hong Jiang; Ning-Ai Liu; Mark O Goodarzi
Journal:  Mol Endocrinol       Date:  2014-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.